Skip to main content Accessibility help
×
Home
Hostname: page-component-cf9d5c678-dksz7 Total loading time: 0.239 Render date: 2021-08-04T10:37:23.932Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Reliability of basal plasma vasopressin concentrations in healthy male adults

Published online by Cambridge University Press:  07 December 2016

Daniel S. Quintana
Affiliation:
NORMENT KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway
Lars T. Westlye
Affiliation:
NORMENT KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway Department of Psychology, University of Oslo, Oslo, Norway
Knut T. Smerud
Affiliation:
Smerud Medical Research International AS, Oslo, Norway
Ramy A. Mahmoud
Affiliation:
OptiNose US Inc., Yardley, PA, USA
Per G. Djupesland
Affiliation:
OptiNose AS, Oslo, Norway
Ole A. Andreassen
Affiliation:
NORMENT KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway
Corresponding

Abstract

Objective

The neuropeptides oxytocin (OT) and arginine vasopressin (AVP) play important and interrelated roles in modulating mammalian social behaviour. While the OT system has received considerable research attention for its potential to treat psychiatric symptoms, comparatively little is known about the role of the AVP system in human social behaviour. To better understand the intraindividual stability of basal AVP, the present study assessed the reproducibility of basal plasma AVP concentrations.

Methods

Basal plasma AVP was assessed at four sampling points separated by 8 days, on average, in 16 healthy adult males.

Results

Only one out of six comparisons revealed strong evidence for reproducibility of basal AVP concentrations (visit 2 vs. visit 4: r=0.8, p<0.001; all other comparisons p>0.1). The concordance correlation coefficient [0.15, 95% CI (−0.55, 0.73)] also revealed poor overall reproducibility.

Conclusion

Poor reliability of basal AVP concentrations suggests future work covarying AVP with trait markers should proceed with careful consideration of intraindividual fluctuations.

Type
Short Communications
Copyright
© Scandinavian College of Neuropsychopharmacology 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Neumann, ID, Landgraf, R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci 2012;35:649659.CrossRefGoogle ScholarPubMed
2. Acher, R, Chauvet, J, Chauvet, MT. Phylogeny of the neurohypophysial hormones. Eur J Biochem 1970;17:509513.CrossRefGoogle ScholarPubMed
3. Winslow, JT, Hastings, N, Carter, CS, Harbaugh, CR, Insel, TR. A role for central vasopressin in pair bonding in monogamous prairie voles. Nature 1993;365:545548.CrossRefGoogle ScholarPubMed
4. Quintana, DS, Guastella, AJ, Westlye, LT, Andreassen, OA. The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders. Mol Psychiatry 2015;21:2938.CrossRefGoogle ScholarPubMed
5. Pietrowsky, R, Strüben, C, Mölle, M, Fehm, HL, Born, J. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans. Biol Psychiatry 1996;39:332340.CrossRefGoogle ScholarPubMed
6. Guastella, AJ, Kenyon, AR, Alvares, GA, Carson, DS, Hickie, IB. Intranasal arginine vasopressin enhances the encoding of happy and angry faces in humans. Biol Psychiatry 2010;67:12201222.CrossRefGoogle ScholarPubMed
7. Uzefovsky, F, Shalev, I, Israel, S, Knafo, A, Ebstein, RP. Vasopressin selectively impairs emotion recognition in men. Psychoneuroendocrinology 2012;37:576580.CrossRefGoogle ScholarPubMed
8. Boso, M, Emanuele, E, Politi, P et al. Reduced plasma apelin levels in patients with autistic spectrum disorder. Arch Med Res 2007;38:7074.CrossRefGoogle ScholarPubMed
9. Miller, M, Bales, KL, Taylor, SL et al. Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms. Autism Res 2013;6:91102.CrossRefGoogle ScholarPubMed
10. Rubin, LH, Carter, CS, Bishop, JR et al. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull 2014;40:13741384.CrossRefGoogle ScholarPubMed
11. Jobst, A, Dehning, S, Ruf, S et al. Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients. Acta Neuropsych 2014;26:347355.CrossRefGoogle ScholarPubMed
12. Gouin, J-P, Carter, CS, Pournajafi-Nazarloo, H et al. Plasma vasopressin and interpersonal functioning. Biol Psychol 2012;91:270274.CrossRefGoogle ScholarPubMed
13. Carson, DS, Garner, JP, Hyde, SA et al. Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism. PLoS One 2015;10:e0132224.CrossRefGoogle ScholarPubMed
14. Zhang, H-F, Dai, Y-C, Wu, J et al. Plasma oxytocin and arginine-vasopressin levels in children with autism spectrum disorder in China: associations with symptoms. Neurosci Bull 2016;32:423432.CrossRefGoogle ScholarPubMed
15. Rubin, LH, Carter, CS, Bishop, JR et al. Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis. Schizophr Res 2013;146:138143.CrossRefGoogle Scholar
16. Stachenfeld, NS, DiPietro, L, Kokoszka, CA, Silva, C, Keefe, DL, Nadel, ER. Physiological variability of fluid-regulation hormones in young women. J Appl Physiol 1999;86:10921096.Google ScholarPubMed
17. Weisman, O, Schneiderman, I, Zagoory-Sharon, O, Feldman, R. Salivary vasopressin increases following intranasal oxytocin administration. Peptides 2013;40:99103.CrossRefGoogle ScholarPubMed
18. Lin, L. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989:255268.CrossRefGoogle ScholarPubMed
19. Quintana, DS, Westlye, LT, Rustan, ØG et al. Low dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized 4-way crossover trial with nasal cavity dimension assessment. Transl Psychiatry 2015;5:19.CrossRefGoogle Scholar
20. Quintana, DS, Westlye, LT, Alnæs, D et al. Low dose intranasal oxytocin delivered with breath powered device dampens amygdala response to emotional stimuli: a peripheral effect-controlled within-subjects randomized dose-response fMRI trial. Psychoneuroendocrinology 2016;69:180188.CrossRefGoogle ScholarPubMed
21. Wechsler, D. Weschsler Abbreviated Scale of Intelligence. San Antonio, TX: Psychological Corporation, 1999.Google Scholar
22. Lecrubier, Y, Sheehan, D, Weiller, E et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997;12:224231.CrossRefGoogle Scholar
23. Spielberger, CD. Manual for the State-Trait Anxiety Inventory STAI (form Y) (‘self-evaluation questionnaire’), Palo Alto, CA: Consulting Psychologists Press, 1983.Google Scholar
24. JASP Team (2016). JASP (Version 0.8.0.0) [Computer software].Google Scholar
25. Cool, DR, DeBrosse, D. Extraction of oxytocin and arginine–vasopressin from serum and plasma for radioimmunoassay and surface-enhanced laser desorption–ionization time-of-flight mass spectrometry. J Chromatogr B 2003;792:375380.CrossRefGoogle ScholarPubMed
26. Valstad, M, Alvares, GA, Andreassen, OA, Westlye, LT, Quintana, DS. The relationship between central and peripheral oxytocin concentrations: a systematic review and meta-analysis protocol. Syst Rev 2016;5:17.CrossRefGoogle ScholarPubMed
27. Kagerbauer, S, Martin, J, Schuster, T, Blobner, M, Kochs, E, Landgraf, R. Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid. J Neuroendocrinol 2013;25:668673.CrossRefGoogle Scholar
28. Leng, G, Ludwig, M. Intranasal oxytocin: myths and delusions. Biol Psychiatry 2016;79:243250.CrossRefGoogle ScholarPubMed
29. Thompson, R, George, K, Walton, J, Orr, S, Benson, J. Sex-specific influences of vasopressin on human social communication. Proc Natl Acad Sci 2006;103:78897894.CrossRefGoogle ScholarPubMed
Supplementary material: File

Quintana Mendoza supplementary material

Supplementary Table and Figure

Download Quintana Mendoza supplementary material(File)
File 140 KB
4
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Reliability of basal plasma vasopressin concentrations in healthy male adults
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Reliability of basal plasma vasopressin concentrations in healthy male adults
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Reliability of basal plasma vasopressin concentrations in healthy male adults
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *